Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models

H. Zhang, B. L. Hylander, C. Levea, E. A. Repasky, R. M. Straubinger, A. A. Adjei, W. W. Ma

Research output: Contribution to journalArticle

21 Scopus citations

Fingerprint Dive into the research topics of 'Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models'. Together they form a unique fingerprint.

Medicine & Life Sciences